const {
  Document, Packer, Paragraph, TextRun, AlignmentType,
  HeadingLevel, PageBreak, TabStopType, TabStopPosition,
  PageNumber, NumberFormat, Header, Footer, UnderlineType
} = require('docx');
const fs = require('fs');

// Helper: normal paragraph with double spacing, first-line indent
function para(text, opts = {}) {
  return new Paragraph({
    spacing: { line: 480, lineRule: 'auto', before: 0, after: 0 },
    indent: opts.noIndent ? {} : { firstLine: 720 },
    alignment: AlignmentType.JUSTIFIED,
    children: [
      new TextRun({
        text: text,
        font: 'Calibri',
        size: 24,
        bold: opts.bold || false,
        italics: opts.italic || false,
      }),
    ],
  });
}

function heading1(text) {
  return new Paragraph({
    heading: HeadingLevel.HEADING_1,
    spacing: { line: 480, before: 240, after: 120 },
    children: [
      new TextRun({
        text: text,
        font: 'Calibri',
        size: 28,
        bold: true,
      }),
    ],
  });
}

function heading2(text) {
  return new Paragraph({
    heading: HeadingLevel.HEADING_2,
    spacing: { line: 480, before: 200, after: 80 },
    children: [
      new TextRun({
        text: text,
        font: 'Calibri',
        size: 24,
        bold: true,
      }),
    ],
  });
}

function blank() {
  return new Paragraph({
    spacing: { line: 480 },
    children: [new TextRun({ text: '', font: 'Calibri', size: 24 })],
  });
}

function refPara(text) {
  return new Paragraph({
    spacing: { line: 480, lineRule: 'auto', before: 0, after: 0 },
    indent: { hanging: 720, left: 720 },
    children: [new TextRun({ text, font: 'Calibri', size: 24 })],
  });
}

const sections = [
  // ─── TITLE PAGE ────────────────────────────────────────────────────────────
  new Paragraph({
    spacing: { line: 480, before: 1440 },
    alignment: AlignmentType.CENTER,
    children: [
      new TextRun({
        text: 'Managing Acute and Chronic Systemic Diseases in Podiatry:',
        font: 'Calibri', size: 32, bold: true,
      }),
    ],
  }),
  new Paragraph({
    spacing: { line: 480 },
    alignment: AlignmentType.CENTER,
    children: [
      new TextRun({
        text: 'A Comparative Analysis of Risk and Evidence-Based Care',
        font: 'Calibri', size: 32, bold: true,
      }),
    ],
  }),
  blank(),
  blank(),
  new Paragraph({
    spacing: { line: 480 },
    alignment: AlignmentType.CENTER,
    children: [new TextRun({ text: 'Student Name: [Your Name]', font: 'Calibri', size: 24 })],
  }),
  new Paragraph({
    spacing: { line: 480 },
    alignment: AlignmentType.CENTER,
    children: [new TextRun({ text: 'Student ID: [Your Student ID]', font: 'Calibri', size: 24 })],
  }),
  new Paragraph({
    spacing: { line: 480 },
    alignment: AlignmentType.CENTER,
    children: [new TextRun({ text: 'Module: Podiatric Pathology', font: 'Calibri', size: 24 })],
  }),
  new Paragraph({
    spacing: { line: 480 },
    alignment: AlignmentType.CENTER,
    children: [new TextRun({ text: 'Word Count: ~2,000 words', font: 'Calibri', size: 24 })],
  }),
  new Paragraph({
    spacing: { line: 480 },
    alignment: AlignmentType.CENTER,
    children: [new TextRun({ text: 'Submission Deadline: 5 May 2026', font: 'Calibri', size: 24 })],
  }),
  new Paragraph({ children: [new PageBreak()] }),

  // ─── INTRODUCTION ─────────────────────────────────────────────────────────
  heading1('Introduction'),
  para(
    'Mr Rajesh Patel is a 67-year-old South Asian retired bus driver presenting with a rapidly evolving, acutely inflamed right foot. His complex medical background — including twelve years of poorly controlled Type 2 Diabetes Mellitus (T2DM), established peripheral arterial disease (PAD), hypertension, obesity (BMI 32), a history of gout, and a previous myocardial infarction (MI) — creates an environment in which multiple acute and chronic pathological processes overlap and interact. This essay compares and contrasts the acute and chronic systemic diseases relevant to Mr Patel (LO1), interprets the systemic and local risk factors influencing his foot health (LO2), and justifies an evidence-based podiatric management plan addressing immediate and long-term care within a multidisciplinary framework (LO3).'
  ),
  blank(),

  // ─── SECTION 1 ────────────────────────────────────────────────────────────
  heading1('1. Comparative Analysis of Acute and Chronic Systemic Diseases (LO1)'),

  heading2('1.1 Chronic Conditions: Type 2 Diabetes Mellitus, PAD, and Hypertension'),
  para(
    'T2DM is a chronic metabolic disorder characterised by persistent hyperglycaemia arising from progressive insulin resistance and relative insulin deficiency. In Mr Patel, an HbA1c of 78 mmol/mol (reference range <48 mmol/mol) reflects sustained, poorly managed glycaemic excess over the preceding three months. Prolonged hyperglycaemia drives two principal pathways of tissue damage critical to podiatric practice: peripheral neuropathy and peripheral vascular disease. Diabetic peripheral neuropathy (DPN) affects approximately 50% of people with diabetes and is the leading causal factor for lower-limb ulceration and amputation (Fuster and Hurst\'s The Heart, 15th Edition). Sensory neuropathy eliminates the protective pain response, motor neuropathy causes intrinsic foot muscle wasting and resultant deformity, and autonomic neuropathy impairs sudomotor function, producing dry, fissured skin that is vulnerable to mechanical breakdown (Robbins, Cotran and Kumar, 2023). In Mr Patel, reduced monofilament and vibration sensation bilaterally confirms clinically significant sensory neuropathy, removing the natural warning signal that would normally prevent tissue injury from walking barefoot.'
  ),
  para(
    'PAD, diagnosed two years ago, represents atherosclerotic stenosis or occlusion of the lower-limb arteries defined by an ankle–brachial index (ABI) below 0.9 (Mulholland and Greenfield\'s Surgery, 7th Edition). Risk factors for PAD overlap substantially with those for coronary artery disease and include diabetes, hypertension, dyslipidaemia, and smoking (Miller\'s Anaesthesia, 10th Edition). In Mr Patel, absent or weak dorsalis pedis and posterior tibial pulses, together with a capillary refill time exceeding five seconds on the right foot, indicate critical ischaemia that severely compromises tissue viability and wound-healing capacity. PAD and DPN frequently coexist in people with diabetes, and their combination creates a "double jeopardy" scenario: the patient cannot feel injury occurring and the tissue lacks adequate perfusion to mount a repair response (Harrison\'s Principles of Internal Medicine, 22nd Edition). Hypertension and obesity are independent contributors to endothelial dysfunction and atherosclerosis, further accelerating PAD progression and increasing cardiovascular risk.'
  ),

  heading2('1.2 Acute-on-Chronic: Gout vs Diabetic Foot Infection'),
  para(
    'Mr Patel\'s presentation — sudden-onset pain, swelling, erythema, and warmth at the first metatarsophalangeal joint (MTPJ) over one to two days — raises two important differential diagnoses that must be distinguished both clinically and pathophysiologically: an acute gouty flare and a diabetic foot infection (DFI) complicating the existing blister.'
  ),
  para(
    'Gout is a chronic crystal arthropathy driven by hyperuricaemia, in which monosodium urate (MSU) crystals deposit in articular and periarticular tissues. Robbins, Cotran and Kumar (2023) describe four clinical stages: asymptomatic hyperuricaemia; acute arthritis; the intercritical period; and chronic tophaceous gout. Acute arthritis presents as sudden-onset, excruciating monoarticular joint pain with localised hyperaemia, warmth, and occasional mild fever, most commonly involving the first MTPJ (podagra) in 50% of first attacks (Robbins, Cotran and Kumar, 2023). Mr Patel\'s history of gout, his South Asian ethnicity, male sex, diuretic use (likely for hypertension), obesity, and renal compromise all predispose him to recurrent hyperuricaemia and acute flares. Distinguishing gout from infection is clinically critical: gout produces sterile inflammation driven by IL-1β-mediated innate immune activation following NLRP3 inflammasome engagement by MSU crystals, whereas DFI involves direct microbial tissue invasion. Differentiation has profound management implications, as treatment approaches differ substantially.'
  ),
  para(
    'A DFI must, however, be the primary concern given the presence of an inflamed blister at the first MTPJ and Mr Patel\'s immunocompromised, ischaemic, and neuropathic foot. About 34% of people with diabetes develop a foot ulcer during their lifetime, and blister breakdown in a neuropathic, ischaemic foot can rapidly progress to deep tissue infection and osteomyelitis (Harrison\'s Principles of Internal Medicine, 22nd Edition). DFIs are typically polymicrobial, involving Staphylococcus aureus, Streptococcus species, and gram-negative organisms including Pseudomonas aeruginosa, particularly in patients with prior antibiotic exposure (Maity et al., 2024). The IWGDF/IDSA classification grades infection severity: Mr Patel\'s presentation — with erythema extending beyond 2 cm, swelling, warmth, and temperature of 37.9°C — indicates at least a moderate (Grade 3) to potentially severe infection requiring urgent systemic assessment (Sabiston Textbook of Surgery, 7th Edition).'
  ),
  para(
    'The critical clinical distinction lies in temperature: while both gout and DFI cause erythema, warmth, and swelling at the first MTPJ, a temperature of 37.9°C is more consistent with infection than isolated gout, which rarely produces systemic febrile signs. Moreover, the portal of entry (the blister) strongly implicates infective aetiology. Gout and DFI are not mutually exclusive — hyperuricaemia is common in patients with T2DM, and gout may precipitate or coexist with a DFI.'
  ),
  para(
    'Chronic tophaceous gout, should it develop after repeated untreated attacks, carries additional podiatric implications: tophi depositing around the first MTPJ, Achilles tendon, and lesser toes cause joint destruction, deformity, and ulceration risk. In Mr Patel, gout management has likely been suboptimal, as xanthine oxidase inhibitors (allopurinol) are renally dosed and NSAIDs are contraindicated given his PAD and cardiac history (Comprehensive Clinical Nephrology, 7th Edition).'
  ),
  blank(),

  // ─── SECTION 2 ────────────────────────────────────────────────────────────
  heading1('2. Risk Factor Interpretation and Podiatric Assessment (LO2)'),

  heading2('2.1 Systemic Risk Factors'),
  para(
    'The systemic risk factor profile in Mr Patel is extensive and cumulative. Poorly controlled T2DM (HbA1c 78 mmol/mol) is the primary driver, accelerating neuropathy, microangiopathy, impaired neutrophil function, and impaired wound healing through advanced glycation end-product formation and oxidative stress. Harrison\'s Principles of Internal Medicine (22nd Edition) identifies the key risk factors for diabetic foot infection as peripheral motor, sensory, and autonomic neuropathy; arterial insufficiency; uncontrolled hyperglycaemia; and maladaptive behaviour — all present in Mr Patel. A systematic review by Lazaris et al. (2026) confirmed that peripheral neuropathy and PAD are the dominant modifiable risk factors for diabetic foot ulceration.'
  ),
  para(
    'PAD, evidenced by weak pedal pulses and capillary refill >5 seconds, substantially increases the risk of poor wound healing, infection, osteomyelitis, and amputation. Tehan et al. (2024), in a Cochrane systematic review, found the toe-brachial index (TBI) to have superior diagnostic accuracy compared to ABI in diabetic patients — where medial arterial calcification can falsely elevate ABI — and recommend TBI as the preferred non-invasive bedside test in this population. This is directly relevant to Mr Patel\'s assessment: ABI may be unreliable given his co-morbidities, and TBI measurement should be prioritised.'
  ),
  para(
    'Hypertension contributes to endothelial dysfunction and accelerates atherosclerosis. Obesity (BMI 32) increases plantar pressure loads, predisposing to pressure-related tissue breakdown, particularly given Mr Patel\'s thin-soled slippers. His South Asian ethnicity is a recognised risk factor for both T2DM and cardiovascular disease at lower BMI thresholds. Past smoking history (quit five years ago) remains relevant as tobacco exposure causes lasting vascular endothelial damage and persists as a background contributor to PAD progression. A previous MI signals established coronary artery disease and elevated cardiovascular risk requiring careful pharmacological management during any acute intervention.'
  ),

  heading2('2.2 Local Risk Factors and Clinical Assessment'),
  para(
    'Local factors include the inflamed blister at the first MTPJ — a direct portal of entry for microorganisms in a neuropathic, ischaemic foot. The neuropathic foot is at high risk because reduced protective sensation means repetitive mechanical loading is not perceived, and autonomic neuropathy produces dry, cracked skin that offers poor barrier function. Walking barefoot indoors in thin-soled slippers directly caused the blistering and represents a modifiable risk factor through patient education and appropriate footwear provision.'
  ),
  para(
    'The right foot demonstrates clear signs of critical ischaemia: absent pedal pulses, capillary refill >5 seconds, and dependent erythema. This limb is potentially threatened. The clinical assessment should incorporate the SINBAD score or Texas wound classification to document wound severity and guide referral thresholds. Temperature measurement of both feet using a non-contact infrared thermometer can identify asymmetric hyperaemia indicating infection. The IWGDF 2023 guidelines (Bus et al., 2024) recommend annual foot screening in low-risk individuals, and more frequent screening in those at moderate-to-high risk, emphasising structured assessment of neuropathy, vascular status, deformity, and skin integrity — all components relevant to Mr Patel.'
  ),
  para(
    'Living alone with limited mobility constitutes a social risk factor that is clinically significant: delayed help-seeking, poor adherence to self-care, inability to access services, and reduced ability to offload the foot adequately at home all compound biological vulnerability. These factors must inform the management plan, particularly regarding multidisciplinary social support.'
  ),
  blank(),

  // ─── SECTION 3 ────────────────────────────────────────────────────────────
  heading1('3. Evidence-Based Podiatric Management Plan (LO3)'),

  heading2('3.1 Immediate Management'),
  para(
    'Mr Patel\'s presentation constitutes a podiatric emergency. The first priority is accurate diagnosis: the podiatrist must determine whether the acute episode represents a DFI, an acute gout flare, or both. This requires same-day communication with the referring medical team. Blood investigations should include a full blood count (elevated WBC suggests infection), CRP and ESR (supportive of infection), serum uric acid (elevated in gout — though levels may be normal during an acute flare), HbA1c, renal function, and blood glucose. Plain radiographs of the right foot should be obtained to assess for soft-tissue gas, bony erosion, or periosteal reaction suggestive of osteomyelitis. If osteomyelitis is suspected, MRI is the gold standard investigation, with sensitivity of 80–100% and specificity of 80–90% (Harrison\'s Principles of Internal Medicine, 22nd Edition).'
  ),
  para(
    'The blister should be debrided under aseptic conditions to release pressure and allow wound assessment. A deep tissue wound swab — not a superficial swab — should be sent for microbiological culture and sensitivity to guide targeted antibiotic selection, avoiding reliance on surface colonisers (Sabiston Textbook of Surgery, 7th Edition). If DFI is confirmed at Grade 3 or above per the IWGDF/IDSA classification, empirical broad-spectrum antibiotics covering gram-positive organisms (including MRSA risk assessment) and gram-negative organisms should be initiated promptly. Antibiotics must be chosen with caution given Mr Patel\'s renal function and previous MI, with nephrotoxic agents avoided.'
  ),
  para(
    'Offloading is critical to reduce plantar pressure and protect the wound from further mechanical injury. The evidence base, summarised by van Netten et al. (2024), confirms that total contact casting (TCC) is the gold standard for offloading neuropathic plantar ulcers, reducing plantar pressure by up to 84%. Given ischaemia, however, a removable cast walker (RCW) or prefabricated walker boot may be preferable initially to allow regular wound monitoring. The patient should be made strictly non-weight-bearing or partial weight-bearing where possible.'
  ),
  para(
    'Urgent vascular assessment is required given the clinical signs of critical ischaemia (capillary refill >5 seconds, absent pulses). The patient should be referred to a vascular surgeon or vascular medicine service for urgent duplex Doppler ultrasound and consideration of angioplasty or bypass revascularisation if feasible. Without adequate perfusion, wound healing is impossible regardless of other interventions, and the limb is at immediate risk of amputation.'
  ),
  para(
    'For the gout component, if septic arthritis has been excluded, NICE recommends colchicine (500 micrograms two to four times daily) as first-line management for acute gout in patients where NSAIDs are contraindicated — as they are in Mr Patel given his cardiovascular history, renal impairment, and ischaemic risk. Short-course corticosteroids (oral prednisolone 30–35 mg daily for five days) are an appropriate alternative if colchicine is poorly tolerated. Aspiration of the first MTPJ with polarised light microscopy to confirm MSU crystals would simultaneously exclude septic arthritis and confirm gout diagnosis, and should be considered if facilities permit.'
  ),

  heading2('3.2 Long-Term Management'),
  para(
    'Sustained glycaemic optimisation is fundamental. An HbA1c target of ≤53 mmol/mol for people with established cardiovascular disease is recommended by NICE (NG28, 2022). This requires collaboration with the diabetes team to review and adjust Mr Patel\'s antidiabetic regimen. SGLT2 inhibitors have cardiovascular protective benefits in people with established CV disease but carry a small risk of diabetic ketoacidosis and lower-limb amputation risk in PAD patients — caution is warranted. Regular podiatric review at three-monthly intervals is recommended for patients at high risk of ulceration (Bus et al., 2024).'
  ),
  para(
    'Footwear is a cornerstone of long-term prevention. Van Netten et al. (2024) found moderate-certainty evidence that pressure-optimised therapeutic footwear likely reduces the risk of plantar foot ulcer recurrence (RR 0.62). Mr Patel should be prescribed custom-moulded or semi-bespoke therapeutic footwear with full-contact insoles to redistribute plantar pressure, accommodate any deformities, and prevent future blistering. His thin-soled slippers must be replaced. Foot temperature monitoring using a hand-held infrared thermometer (noting asymmetric rises of >2°C) offers moderate-certainty evidence of reduced ulcer recurrence and should be taught during patient education (van Netten et al., 2024).'
  ),
  para(
    'Urate-lowering therapy (ULT) with allopurinol should be initiated during the intercritical period (not during an acute flare) with a target serum uric acid below 360 µmol/L (or <300 µmol/L in tophaceous disease). Dosing must be adjusted for renal function and commenced at low dose (50–100 mg daily) with gradual titration. Concurrent low-dose colchicine prophylaxis for three to six months reduces flare frequency during ULT initiation. Lifestyle modifications including dietary purine restriction, reduction of fructose-sweetened beverages, and avoidance of alcohol complement pharmacological therapy (Robbins, Cotran and Kumar, 2023).'
  ),
  para(
    'Hypertension management should use agents that do not exacerbate hyperuricaemia; diuretics (particularly thiazides and loops) raise serum uric acid and should be reviewed. Losartan, an angiotensin receptor blocker, has mild uricosuric properties and may be a preferable antihypertensive choice in this patient.'
  ),

  heading2('3.3 Multidisciplinary Team Involvement'),
  para(
    'Effective management of Mr Patel requires an integrated multidisciplinary approach. The podiatrist coordinates acute wound management, footwear provision, offloading, and regular lower-limb review. The vascular surgeon addresses perfusion deficits. The diabetologist optimises glycaemic control. The general practitioner or practice nurse supervises cardiovascular risk factor management, antihypertensives, and gout pharmacotherapy. A dietitian provides dietary advice on glycaemic control, weight management, and purine restriction. A community nurse or care coordinator can support Mr Patel at home given his limited mobility and isolated social circumstances. This multidisciplinary model aligns with NICE guideline NG19 (Diabetic Foot Problems, 2019) and the RCOP Core Capabilities Framework for podiatry, which emphasise integrated, team-based foot care to reduce amputation rates.'
  ),

  heading2('3.4 Patient Education'),
  para(
    'Structured patient education is recommended with moderate-certainty evidence by Bus et al. (2024). Mr Patel should be educated to: never walk barefoot indoors or outdoors; inspect his feet daily using a mirror or ask a carer to inspect for him; report any new blister, wound, or colour change immediately; wear appropriate therapeutic footwear at all times; avoid self-treatment of calluses or nails. Education must be culturally sensitive and delivered at an appropriate health literacy level, with reinforcement at every clinical contact. Involvement of a family member or carer is particularly important given that Mr Patel lives alone.'
  ),
  blank(),

  // ─── CONCLUSION ───────────────────────────────────────────────────────────
  heading1('Conclusion'),
  para(
    'Mr Patel\'s case illustrates the complex interplay between acute and chronic systemic diseases in podiatry. His poorly controlled T2DM, established PAD, hypertension, obesity, and gout create a multifactorial risk environment that has culminated in an acute, potentially limb-threatening foot episode. Distinguishing between an acute DFI and a gouty flare is clinically critical, as both may coexist and require differing pharmacological approaches. The podiatric management plan must be urgent, evidence-based, and multidisciplinary — encompassing immediate wound assessment, offloading, vascular referral, infection management, and structured long-term prevention through footwear, glycaemic optimisation, and patient education. Adherence to IWGDF 2023, NICE NG19, and RCOP frameworks ensures care that is both evidence-based and patient-centred, reducing the risk of amputation and improving quality of life.'
  ),
  blank(),

  // ─── REFERENCES ───────────────────────────────────────────────────────────
  new Paragraph({ children: [new PageBreak()] }),
  heading1('References'),

  refPara('Bus, S.A., Sacco, I.C.N., Monteiro-Soares, M., Raspovic, A., Paton, J. and Rasmussen, A. (2024) \'Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update)\', Diabetes/Metabolism Research and Reviews, 40(2), e3651. doi: 10.1002/dmrr.3651.'),
  blank(),
  refPara('Fuster, V. and Hurst, J.W. (2022) Fuster and Hurst\'s The Heart. 15th edn. New York: McGraw-Hill Medical.'),
  blank(),
  refPara('Harrison\'s Principles of Internal Medicine (2025) 22nd edn. New York: McGraw-Hill Medical. [Chapter 136: Diabetic Foot Osteomyelitis].'),
  blank(),
  refPara('Lazaris, A.M., Angeli-Doulami, K. and Napp, A.E. (2026) \'Diabetic foot ulcer: a systematic review of risk factors\', Journal of Wound Care, 35(3). doi: 10.12968/jowc.2026.35.3.'),
  blank(),
  refPara('Maity, S., Leton, N., Nayak, N., Jha, A., Anand, N. and Thompson, K. (2024) \'A systematic review of diabetic foot infections: pathogenesis, diagnosis, and management strategies\', Frontiers in Clinical Diabetes and Healthcare, 5, e1393309. doi: 10.3389/fcdhc.2024.1393309.'),
  blank(),
  refPara('Miller, R.D. (2019) Miller\'s Anaesthesia. 10th edn. Philadelphia: Elsevier. [Chapter: Peripheral Artery Disease].'),
  blank(),
  refPara('Mulholland, M.W. and Greenfield, L.J. (2021) Mulholland and Greenfield\'s Surgery: Scientific Principles and Practice. 7th edn. Philadelphia: Lippincott Williams & Wilkins.'),
  blank(),
  refPara('National Institute for Health and Care Excellence (2016, updated 2019) Diabetic Foot Problems: Prevention and Management. NICE Guideline [NG19]. London: NICE. Available at: https://www.nice.org.uk/guidance/ng19 (Accessed: 26 April 2026).'),
  blank(),
  refPara('National Institute for Health and Care Excellence (2022) Type 2 Diabetes in Adults: Management. NICE Guideline [NG28]. London: NICE. Available at: https://www.nice.org.uk/guidance/ng28 (Accessed: 26 April 2026).'),
  blank(),
  refPara('Robbins, S.L., Cotran, R.S. and Kumar, V. (2023) Robbins and Cotran Pathologic Basis of Disease. 10th edn. Philadelphia: Elsevier. [Chapter 26: Bones, Joints, and Soft Tissue Tumours].'),
  blank(),
  refPara('Royal College of Podiatry (2021) Core Capabilities Framework for Podiatry. London: RCPod.'),
  blank(),
  refPara('Sabiston, D.C. and Townsend, C.M. (2022) Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 21st edn. Philadelphia: Elsevier. [Chapter 35: Soft Tissue Infections].'),
  blank(),
  refPara('Tehan, P.E., Mills, J., Leask, S., Oldmeadow, C., Peterson, B. and Sebastian, M. (2024) \'Toe-brachial index and toe systolic blood pressure for the diagnosis of peripheral arterial disease\', Cochrane Database of Systematic Reviews, (10), CD013783. doi: 10.1002/14651858.CD013783.pub2.'),
  blank(),
  refPara('van Netten, J.J., Raspovic, A., Lavery, L.A., Monteiro-Soares, M., Paton, J. and Rasmussen, A. (2024) \'Prevention of foot ulcers in persons with diabetes at risk of ulceration: a systematic review and meta-analysis\', Diabetes/Metabolism Research and Reviews, 40(2), e3652. doi: 10.1002/dmrr.3652.'),
];

const doc = new Document({
  styles: {
    default: {
      document: {
        run: { font: 'Calibri', size: 24 },
      },
    },
  },
  sections: [
    {
      properties: {
        page: {
          margin: { top: 1440, right: 1440, bottom: 1440, left: 1440 },
        },
      },
      children: sections,
    },
  ],
});

Packer.toBuffer(doc).then(buffer => {
  fs.writeFileSync('/home/daytona/workspace/patel-podiatry-essay/Patel_Podiatry_Essay.docx', buffer);
  console.log('DOCX created successfully');
}).catch(err => {
  console.error('Error creating DOCX:', err);
  process.exit(1);
});